RD

Rahul Dadasaheb Wagh

Active Director Director DIN 10890591
DIN 10890591 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rahul Dadasaheb Wagh

Data last updated:

Rahul Dadasaheb Wagh is a Director at Acopt Pharmaceutical Private Limited (since 2024).

DIN 10890591
Primary Designation Director
First Appointment 29 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acopt Pharmaceutical Private Limited U46497MH2024PTC437270
Director29 Dec 20242024Active

Board colleagues of Rahul Dadasaheb Wagh

NameDINCompanyDesignation
Yogesh Pandurang Bhakare10890590Acopt Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Acopt Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rahul Dadasaheb Wagh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Dadasaheb Wagh

Rahul Dadasaheb Wagh currently holds 1 directorship: Acopt Pharmaceutical Private Limited (Director, since 29 Dec 2024).

Rahul Dadasaheb Wagh was first appointed on 29 Dec 2024 as Director at Acopt Pharmaceutical Private Limited.

The current boards of Rahul Dadasaheb Wagh's companies include Yogesh Pandurang Bhakare (Acopt Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available